Leaders in Biotechnology and Drug Development to Attend April Meeting in St. Louis
DANBURY, Conn., March 19 /PRNewswire-USNewswire/ -- The Society for Biomolecular Sciences (SBS) today announced its outstanding roster of keynote speakers for its 14th Annual Conference & Exhibition to be held April 6-10 at America's Center in St. Louis, MO. More than 2,500 leaders in the pharmaceutical and biotech industries from around the world are expected to attend the 2008 Conference to discuss advances in biotechnology, challenges and automation solutions in the field.
Leading presentations for the five-day event will be Janet Woodcock, M.D., deputy commissioner and chief medical officer for the U.S. Food & Drug Administration. Dr. Woodcock, who oversees scientific and medical regulatory operations for the FDA, will speak on "The Promise of Molecular Medicine." Dr. Woodcock most recently served as the FDA's Deputy Commissioner for Operations and Chief Operating Officer and as the Director of the FDA's Center for Drug Evaluation.
Joining Dr. Woodcock as a keynote speaker will be Jonathan D. Gitlin, M.D., the Helene B. Roberson Professor of Pediatrics and Professor of Genetics at the Washington University School of Medicine. Dr. Gitlin's speech entitled "Child Health Research in the 21st Century: Obstacles and Opportunities," will address whether diseases such as Alzheimer's, diabetes and obesity are already genetically encoded in individuals while still in the womb, and can possibly be prevented with genetic engineering before birth.
Completing the keynote speaker line-up will be Jeffrey I. Gordon, M.D., the Robert J. Glaser Distinguished University Professor at Washington University School of Medicine. Dr. Gordon's speech is entitled "Dining in With a Few Trillion Friends: Exploring the Human Gut Microbiota and Microbiome." Dr. Gordon has also served as the head of molecular biology and pharmacology at Washington University School of Medicine and was director of the University's division of biology and biomedical sciences.
The Society for Biomolecular Sciences (SBS) is the only international non-profit scientific society dedicated to drug discovery and its related disciplines. Founded in 1994, the Society provides a forum for global education and information exchange among professionals in the chemical, pharmaceutical, biotech and agrochemical industries. SBS was developed in an effort to advance the science of drug discovery and related disciplines by providing a forum for education and information exchange among professionals around the world.
For further information on the SBS 14th Annual Conference and Exhibition, visit www.sbsonline.org or contact Jennifer Bender or Rosalind D'Eugenio at (203) 325-8772, or [email protected]
SOURCE Society for Biomolecular Sciences